首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
ANORDNING OCH FOERFARANDE FOER APPLICERING AV EN VAETSKA PAO EN YTA
摘要
申请公布号
FI832839(A0)
申请公布日期
1983.08.08
申请号
FI19830002839
申请日期
1983.08.08
申请人
WILLETT INTERNATIONAL LIMITED
发明人
WILLETT, ALLAN;KEELING, MICHAEL RICHARD
分类号
B05B5/08;B05B15/02;B05B17/06;B05D1/04;B41J2/08;(IPC1-7):B41J/
主分类号
B05B5/08
代理机构
代理人
主权项
地址
您可能感兴趣的专利
FremgangsmÕte og anordning for temperaturuavhengig lagring
CROSS CONNECT SYSTEM AND THE ELECTRICAL CONNECTION PLUG USED IN THIS FOR TELECOMMUNICATIONS SYSTEMS
SAUCE- AND SAUSAGE WITH MUSHROOM, PROCESS FOR PRODUCING, AND USING THEREOF
A METHOD AND APPARATUS FOR BUILDING A LAMINATE AND FORMING A CARCASS FOR A TIRE FROM AN ASSEMBLY OF TIRE COMPONENTS
NEW PHENANTHRIDINES DERIVATIVES, USE THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
PROCESS FOR PRODUCING DIFLUOROMETHYL METHYL ETHER
A MICROWAVE ENERGY GENERATION DEVICE USED TO FACILITATE REMOVAL OF CONCRETE FROM A METAL CONTAINER
PROCESS FOR PRODUCING FORMYLIMIDAZOL DERIVATIVES
DOSAGE FORM FOR MICRO-BUBLE ECHO CONTRAST AGENTS
TOOL AND TOOL HOLDER FOR POWER TOOLS
USE OF 4-AMINO-4-(4-FLUOROBENZYLAMINO)-1-ETHOXY-CARBONYLAMINOBENZENE FOR PROPHYLAXIS AND TREATMENT OF SEQUELAE OF REDUCED CIRCULATION IN THE BRAIN AND NEURODEGENERATIVE DISORDERS
HORMONE PATCH
PERCUTANEOUS PREPARATIONS COMPRISING TULOBUTEROL
ENZYME AND MICROORGANISM DEGRADING RHAMNOGALACTURONANE II
TREATMENT OF INFLAMMATORY BOWEL DISEASE USING ORAL DOSAGE FORMS OF OMEGA-3 POLYUNSATURATED ACIDS
PROCESS FOR PRODUCING OF PHARMACEUTICAL COMPOSITIONS WHICH SELECTIVELY BIND A SELECTIN RECEPTOR
USE OF TOMOXETIN FOR THE PRODUCTION OF MEDICAMENTS AGAINST ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
COMPOSITION FOR PH DEPENDENT CONTROLLED RELEASE OF ACTIVE INGREDIENTS AND METHODS FOR PRODUCING IT
PYRROLOPYRROLONE DERIVATIVES AS INHIBITORS OF NEUTROPHIL ELASTASE, INTERMEDIATES, PREPARATION AND USE THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
INDOLINONE DERIVATIVES FOR THE TREATMENT OF DISEASE, USE THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
